Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia
- PMID: 20177883
- DOI: 10.1007/s00213-010-1787-x
Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia
Abstract
Background: Studies have also shown that differences in the kind of the antipsychotics influenced disruption of the sensorimotor gating system, including prepulse inhibition (PPI), acoustic startle reflex (ASR), and habituation (HAB). We investigated the influence on startle response in chronic schizophrenia in 20 patients with schizophrenia taking risperidone, 21 patients with schizophrenia taking olanzapine, and 20 patients with schizophrenia taking aripiprazole.
Method: The patients who participated in this study were on maintenance therapy with only one antipsychotic drug for 4 months. We performed the test for the association between all PPI measures (ASR, HAB, and PPI at prepulse sound pressure intensities of 82, 86, and 90 dB) and each the risperidene, olanzapine, and aripiprazole groups, with analysis of covariance (ANCOVA; using age, duration of illness, and daily dose of the antipsychotic as covariates). Also, when significant difference was detected in ANCOVA, the differences of PPI measures between every pairs of two drug groups were tested as a post hoc analysis with the use of t test and Bonferroni's correction of multiple tests.
Result: We found that PPI90 showed significant differences with ANCOVA among patients with schizophrenia taking each of the antipsychotics. When we performed a post hoc analysis for PPI90, the value was higher in the aripiprazole group than in the olanzapine group and higher in the risperidone group than in the olanzapine group.
Conclusion: Aripiprazole and risperidone may improve PPI90. ASR, HAB, PPI82, and PPI86 were no different among the Japanese schizophrenic patient groups with different antipsychotics.
Similar articles
-
Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol.Psychiatry Res. 2003 Aug 30;120(1):1-12. doi: 10.1016/s0165-1781(03)00161-6. Psychiatry Res. 2003. PMID: 14500109
-
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial.Schizophr Res. 2007 Sep;95(1-3):134-42. doi: 10.1016/j.schres.2007.05.039. Epub 2007 Jul 26. Schizophr Res. 2007. PMID: 17662577 Free PMC article. Clinical Trial.
-
A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics.Int J Neuropsychopharmacol. 2007 Aug;10(4):463-77. doi: 10.1017/S1461145706007139. Epub 2006 Aug 21. Int J Neuropsychopharmacol. 2007. PMID: 16923324 Clinical Trial.
-
Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials.Psychopharmacol Bull. 2010;43(2):45-66. Psychopharmacol Bull. 2010. PMID: 21052042 Review.
-
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Hum Psychopharmacol. 2011. PMID: 23055416 Review.
Cited by
-
Neonatal phencyclidine as a model of sex-biased schizophrenia symptomatology in adolescent mice.Psychopharmacology (Berl). 2023 Oct;240(10):2111-2129. doi: 10.1007/s00213-023-06434-3. Epub 2023 Aug 2. Psychopharmacology (Berl). 2023. PMID: 37530885
-
Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.Neuropsychopharmacology. 2011 Jun;36(7):1489-504. doi: 10.1038/npp.2011.34. Epub 2011 Mar 23. Neuropsychopharmacology. 2011. PMID: 21430651 Free PMC article.
-
The relationship between acoustic startle response measures and cognitive functions in Japanese patients with schizophrenia.Neuromolecular Med. 2012 Jun;14(2):131-8. doi: 10.1007/s12017-012-8177-y. Epub 2012 Mar 28. Neuromolecular Med. 2012. PMID: 22454047
-
Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease.Clin Psychopharmacol Neurosci. 2011 Dec;9(3):102-10. doi: 10.9758/cpn.2011.9.3.102. Epub 2011 Dec 31. Clin Psychopharmacol Neurosci. 2011. PMID: 23429840 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous